Japan Nods Include Torii's Vtama, Skyrizi In New Uses

Concomitant Use Rules Also Revised

 
• By Lisa Takagi

Japan issues approval recommendations in new indications, including Torii's Vtama in atopic dermatitis and AbbVie's Skyrizi in ulcerative colitis. Separately, filing requirements for the use of concomitant therapies have been revised.

Japan cautiously eased approval process for concomitant therapeutics used in combination therapy.
Japan cautiously eased approval process for concomitant therapeutics used in combination therapy. • Source: Shutterstock

More from Japan

More from Asia